Cash Equivalents - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Cash Equivalents Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Cash Equivalents
â‚Ş101.1m
CAGR 3-Years
39%
CAGR 5-Years
97%
CAGR 10-Years
63%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Cash Equivalents
$2.3B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
9%
Redhill Biopharma Ltd
NASDAQ:RDHL
Cash Equivalents
$7.3m
CAGR 3-Years
-48%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash Equivalents
$11.5m
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Cash Equivalents
$3.8m
CAGR 3-Years
-40%
CAGR 5-Years
-31%
CAGR 10-Years
-16%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash Equivalents
â‚Ş11m
CAGR 3-Years
-34%
CAGR 5-Years
-30%
CAGR 10-Years
-11%

See Also

What is InterCure Ltd's Cash Equivalents?
Cash Equivalents
101.1m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Cash Equivalents amounts to 101.1m ILS.

What is InterCure Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
63%

Over the last year, the Cash Equivalents growth was -57%. The average annual Cash Equivalents growth rates for InterCure Ltd have been 39% over the past three years , 97% over the past five years , and 63% over the past ten years .

Back to Top